According to the HER2 detection guidelines in breast cancer issued by the American Society of Clinical Oncology/College of American Pathologists, HER2 amplification is defined as HER2/chromosome enumeration probe 17 [CEP17] ratio ≥ 2.0 (22). This evidence concerns the gene ERBB2 and breast carcinoma.